HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

485.171

+2.8150.58%

Number of Gainers:21

Number of Losers:10

Number of Flat:2

PE:- -

High:489.931

Open:482.072

Low:481.405

Close:482.357

Volume:61.61M

Turnover:1.28B

Market Cap:307.98B

Float Cap:273.83B

Loading ...

HK Business Breakthrough Drives Nearly 5% Intraday Rally for CARSGEN-B

Regulatory Intervention Halts Trading of Eye-Care Drug Developer Following Suspected IPO Irregularities

Venus Medtech Plans 500 Million Yuan Share, Convertible Bond Subscription

MT Newswires Live

Ocumension Therapeutics Says NMPA Accepts NDA for OT-301 (NCX 470, Bimatoprost Grenod)

OCUMENSION-B (01477) NDA for OT-301 Accepted by Chinese Drug Regulator

Ocumension Says China NMPA Accepts OT-301 Glaucoma Drug Application

Ocumension Therapeutics - Nmpa Accepts Nda for Ot-301 (Ncx 470, Bimatoprost Grenod) in China

THOMSON REUTERS

HBM Holdings FY26 H1 Profit Falls 11.16% to US$ 64.85 Million; Revenue Rises 20.9% to US$ 122.49 Million

Venus Medtech Hangzhou - to Issue 184.5 Mln Shares and Hk$379.7 Mln Convertible Bonds

THOMSON REUTERS

Venus Medtech Hangzhou - Subscription Price Per Share is Hk$1.078

THOMSON REUTERS

Venus MedTech Agrees Private Placement of 184,536,703 Shares at HKD 1.08 Each

Alphamab Oncology Files HKEX Next-Day Return Disclosing Share Buyback at HKD 8.28 Each

Market Wrap September 10: Innovation Drug Shares Dip Amid Clinical Setback, Bank Stocks Post Modest Gains

AH Share Premium Rankings: September 10 Market Close Update

Tellgen's Subsidiary Device Registration Application Accepted by Regulator

Northeast Securities: Innovative Drug BD and Commercialization Deliver Consistent Wins, CXO Exceeds Projections, Traditional Segments Approach Turnaround

Ascletis Pharma Surges on US Obesity Drug Trial Launch

Hong Kong Stock Market Highlights: JXR Advances Female Health Translational Medicine Platform

AI-Driven Drug Candidate From INSILICO Reaches Major Milestone As Phase 3 Trial Enrolls First Patients

LIFETECH SCI's LantvalTM Aortic Valve Replacement System Clears NMPA Fast-Track Review for Innovative Devices

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK1574/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":485.17123,"timestamp":1789632487194,"preClose":482.35672,"halted":0,"volume":61610930,"delay":0,"changeRate":0.005835,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":2.814514,"latestTime":"09-17 16:00:00","open":482.07187,"high":489.93134,"low":481.40475,"amount":1281540013.5,"amplitude":0.017677,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789695000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789608600000,1789617600000],[1789621200000,1789632000000]],"pbRate":3.604829,"peRate":160.310337,"turnoverRate":0.002293,"increases":18,"decrements":10,"flats":4,"marketCap":307980316848,"floatMarketCap":273827471128},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":489.93134,"amplitude":0.017677,"preClose":482.35672,"low":481.40475,"pbRate":"3.604829","latestPrice":485.17123,"volume":61610930,"delay":0,"open":482.07187,"prevYearClose":556.26263,"prevWeekClose":483.155,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":496.758,"twentyDayClose":517.015,"sixtyDayClose":440.071,"secType":"PLATE","market":"HK","turnoverRate":0.002293,"peRate":160.310337,"marketCap":307980316848,"floatMarketCap":273827471128,"timestamp":1789632487194,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":21,"down":10,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1195415295","title":"HK Business Breakthrough Drives Nearly 5% Intraday Rally for CARSGEN-B","url":"https://stock-news.laohu8.com/highlight/detail?id=1195415295","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195415295?lang=en_us&edition=fundamental","pubTime":"2026-09-11 10:50","pubTimestamp":1789095018,"startTime":"0","endTime":"0","summary":"CARSGEN-B (02171) saw its share price climb nearly 5% during intraday trading, building on optimistic market sentiment. As of the latest update, shares were up 1.84%, trading at HKD 12.70 with a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","BK1587","02171","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140079980","title":"Regulatory Intervention Halts Trading of Eye-Care Drug Developer Following Suspected IPO Irregularities","url":"https://stock-news.laohu8.com/highlight/detail?id=1140079980","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140079980?lang=en_us&edition=fundamental","pubTime":"2026-09-11 10:00","pubTimestamp":1789092059,"startTime":"0","endTime":"0","summary":"Hong Kong's securities regulator has ordered the suspension of trading in shares of Cloudbreak Pharma (02592.HK), citing serious concerns that the company's initial public offering may have been...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FRHC","IBBQ","159992","BK4127","MEDX","BK1574","LNGR","06978","02592","KCE","IPOS","REDS","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666517821","title":"Venus Medtech Plans 500 Million Yuan Share, Convertible Bond Subscription","url":"https://stock-news.laohu8.com/highlight/detail?id=2666517821","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666517821?lang=en_us&edition=fundamental","pubTime":"2026-09-11 09:43","pubTimestamp":1789091017,"startTime":"0","endTime":"0","summary":"Venus Medtech  entered into a subscription agreement with Hangzhou Yingzhiqin No. 3 Equity Investment Partnership for up to 500 million yuan of new shares and convertible bonds, according to a Thursday Hong Kong bourse filing.The deal comprises 184.5 million new shares for about 171.9 million yuan and convertible bonds of up to HK$379.7 million.The subscription price is HK$1.078 per share, while the initial conversion price is HK$1.1858.The company said the fundraising will help address liquidity needs, meet near-term financial obligations, and support operations and product development.The subscription remains subject to shareholder and other regulatory approvals.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","TMF","US2Y.BOND","TLT","US7Y.BOND","US10Y.BOND","BK1100","US12M.BOND","BK1574","US30Y.BOND","US3Y.BOND","US5Y.BOND","TLTW","US6M.BOND","02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666451972","title":"Ocumension Therapeutics Says NMPA Accepts NDA for OT-301 (NCX 470, Bimatoprost Grenod)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666451972","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666451972?lang=en_us&edition=fundamental","pubTime":"2026-09-11 07:11","pubTimestamp":1789081906,"startTime":"0","endTime":"0","summary":"Sept 11 (Reuters) - Ocumension Therapeutics <1477.HK>::*NMPA ACCEPTS NDA FOR OT-301 (NCX 470, BIMATOPROST GRENOD) IN CHINA*Further company coverage: 1477.HK* ((Reuters.Briefs@thomsonreuters.com;))((Re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nRSD431L9q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","01477","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147207766","title":"OCUMENSION-B (01477) NDA for OT-301 Accepted by Chinese Drug Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1147207766","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147207766?lang=en_us&edition=fundamental","pubTime":"2026-09-11 07:10","pubTimestamp":1789081826,"startTime":"0","endTime":"0","summary":"OCUMENSION-B (01477) has announced that its New Drug Application (NDA) for OT-301 (NCX 470, Gebe前列素) has been accepted by the Center for Drug Evaluation of China's National Medical Products...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","IPOS","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666478519","title":"Ocumension Says China NMPA Accepts OT-301 Glaucoma Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2666478519","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666478519?lang=en_us&edition=fundamental","pubTime":"2026-09-11 07:00","pubTimestamp":1789081240,"startTime":"0","endTime":"0","summary":"Ocumension says China NMPA accepts OT-301 glaucoma drug applicationOcumension Therapeutics’ China regulator accepted an NDA for OT-301 to lower intraocular pressure in open-angle glaucoma or ocular hy","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL12b5tR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666551942","title":"Ocumension Therapeutics - Nmpa Accepts Nda for Ot-301 (Ncx 470, Bimatoprost Grenod) in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2666551942","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666551942?lang=en_us&edition=fundamental","pubTime":"2026-09-11 07:00","pubTimestamp":1789081227,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nFWN4520Z5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666599377","title":"HBM Holdings FY26 H1 Profit Falls 11.16% to US$ 64.85 Million; Revenue Rises 20.9% to US$ 122.49 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666599377","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666599377?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:38","pubTimestamp":1789047495,"startTime":"0","endTime":"0","summary":"HBM Holdings FY26 H1 profit falls 11.16% to US$ 64.85 million; revenue rises 20.9% to US$ 122.49 millionHBM Holdings reported 2026 first-half revenue up 20.9% to US$122.49 million, while profit fell 1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL9BfBQl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142","BK1583","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666969115","title":"Venus Medtech Hangzhou - to Issue 184.5 Mln Shares and Hk$379.7 Mln Convertible Bonds","url":"https://stock-news.laohu8.com/highlight/detail?id=2666969115","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666969115?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:12","pubTimestamp":1789045939,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nFWN4520CM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02500","BK1574","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666596916","title":"Venus Medtech Hangzhou - Subscription Price Per Share is Hk$1.078","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596916","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596916?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:12","pubTimestamp":1789045939,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nFWN4520CM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","02500","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666596961","title":"Venus MedTech Agrees Private Placement of 184,536,703 Shares at HKD 1.08 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596961","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596961?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:11","pubTimestamp":1789045904,"startTime":"0","endTime":"0","summary":"Venus MedTech agrees private placement of 184,536,703 shares at HKD 1.08 eachVenus Medtech signed a subscription agreement on Sept. 10, 2026 for 184,536,703 new shares at HKD 1.08.Share sale size: HKD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL1grvnL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","02500","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666567647","title":"Alphamab Oncology Files HKEX Next-Day Return Disclosing Share Buyback at HKD 8.28 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2666567647","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666567647?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:42","pubTimestamp":1789036976,"startTime":"0","endTime":"0","summary":"Alphamab Oncology files HKEX next-day return disclosing share buyback at HKD 8.28 eachAlphamab Oncology repurchased 164,000 shares on Sept. 10, holding them as treasury shares; no shares were cancelle","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL4bHKDg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173269814","title":"Market Wrap September 10: Innovation Drug Shares Dip Amid Clinical Setback, Bank Stocks Post Modest Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1173269814","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173269814?lang=en_us&edition=fundamental","pubTime":"2026-09-10 16:55","pubTimestamp":1789030552,"startTime":"0","endTime":"0","summary":"Hong Kong equities extended their losing streak as escalating Middle East tensions and rising oil prices stoked inflation concerns. A combination of factors, including clinical trial risk events,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","LNGR","ABEQ","VMAX","EQRR","159992","MEDX","BK4585","ROPE","BK4588","SPVM","FDN","IBBQ","PRF","DFLV","BKDV","VALQ","VLUE","VUSV","CGVV","SWP","BK1161","BK4550","PY","VTV","TALV","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120089169","title":"AH Share Premium Rankings: September 10 Market Close Update","url":"https://stock-news.laohu8.com/highlight/detail?id=1120089169","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120089169?lang=en_us&edition=fundamental","pubTime":"2026-09-10 16:23","pubTimestamp":1789028611,"startTime":"0","endTime":"0","summary":"As of the market close on September 10, data reveals the latest rankings for A-H share premium ratios, with NE Electric (00042), ZHEJIANG SHIBAO (01057), and HOLLY FUTURES (03678) claiming the top...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1554","HK0000352291.HKD","03130","IE00B29SXG58.USD","LU0862451753.SGD","LU1807302812.USD","LU0345780521.USD","LU0320764755.SGD","BK1148","LU0880133367.SGD","SG9999002463.SGD","LU0531971595.HKD","02218","IE00B3M56506.USD","HK0000320264.USD","LU0417516738.SGD","LU0588546209.SGD","00187","BK1564","03188","LU2394011477.USD","01033","LU1023057109.AUD","BK1574","IE00BVYPNQ40.USD","BK1551","LU0348766576.USD","LU1675838814.USD","LU2778985437.USD","LU0469268626.HKD","LU0049853897.USD","BK1592","02827","LU2177674079.SGD","SG9999004220.SGD","IE00BYV24P56.USD","LU1303224171.USD","BK1198","LU0287142896.SGD","BK1249","06185","BK1506","BK1507","LU1211504680.USD","BK1147","LU0672654166.SGD","83188","BK1170","LU1244550221.USD","BK1514","LU2097828631.EUR","BK1593","IE00BF5LJ272.USD","LU1152091168.USD","SG9999001093.SGD","IE0032431581.USD","LU2039709279.SGD","LU0214875030.USD","LU1224709979.USD","BK1521","LU0052750758.USD","LU2294711473.HKD","LU1770034418.SGD","06826","03200","LU0228659784.USD","BK1515","BK1163","01349","00300","BK1533","LU0082770016.USD","LU0828238088.HKD","LU0061477393.USD","BK1144","HK0000306701.USD","BK1522","159982","LU0327786744.USD","LU1244550494.USD","LU0348816934.USD","LU1481107354.HKD","BK1110","LU0561508036.HKD","02068","LU0082770016.SGD","LU0456854461.SGD","LU0543330566.HKD","BK1141","IE00B031J352.USD","BK1214","LU0163747925.USD","LU2399975544.HKD","LU1242518857.USD","LU1961090484.USD","LU2097828474.EUR","LU1769817096.USD","LU0648948544.HKD","LU0502904849.HKD","IE0008369823.USD","LU0329678170.USD","03750","BK1183","LU0315179316.USD","BK1202","IE00BVYPNP33.GBP","BK1223","LU1880383366.USD","LU0620787316.HKD","BK1191","LU0791590937.USD","LU0359201612.USD","LU0211977185.USD","399300","LU0348825331.USD","IE00BGHQDM52.EUR","LU0828237510.HKD","LU0540923850.HKD","LU1282649067.USD","LU2476274308.USD","LU0501845795.SGD","LU0456846285.SGD","LU1993786604.SGD","LU1046422090.SGD","LU0173614495.USD","LU0165289439.USD","02338","LU0067412154.USD","BK1560","BK1125","LU1504937902.USD","LU0890818403.SGD","LU1366334651.USD","LU0140636845.USD","LU0370786039.SGD","BK1610","LU0359201885.HKD","LU0979878070.USD","82846","IE0008368742.USD","LU0640798160.USD","SG9999011746.SGD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","00317","LU0828237940.HKD","LU1282649810.SGD","LU0488056044.USD","LU0051755006.USD","LU0254981946.USD","LU0531970944.HKD","LU0096374516.USD","LU1831875114.USD","LU0039217434.USD","LU0348788117.USD","LU0737861772.HKD","BK1149","LU0048580855.USD","LU2045819591.USD","LU2226246903.HKD","LU0348805143.USD","01057","LU0516422440.USD","LU0871576103.HKD","LU0348827113.USD","LU1794554557.SGD","BK1583","LU0509642566.USD","00991","LU1064131342.USD","LU0593848301.USD","LU0307460666.USD","BK1576","LU1152091754.HKD","LU0918141705.HKD","LU2097828557.USD","01108","IE00BMCWC346.EUR","LU0329678337.USD","BK1190","HK0000320223.HKD","HK0001040168.HKD","LU0149534421.HKD","LU0516422952.EUR","LU0231483743.USD","LU0868486357.SGD","LU0886674414.USD","06745","LU0634319403.HKD","SG9999014674.SGD","IE00BZ08YT58.USD","LU1048596156.SGD","IE00B031HY20.USD","LU1960683339.HKD","BK1594","83130","LU0266512127.USD","LU0345780281.USD","00895","IE0034224299.USD","LU1282648689.USD","BK1562","LU0269904917.USD","LU0572944931.SGD","LU0128522157.USD","06869","07233","LU0117841782.USD","IE00B543WZ88.USD","SG9999006597.SGD","BK1116","LU0359202008.SGD","SG9999001226.SGD","LU0823426480.USD","03308","LU0164939612.USD","BK1140","00553","BK1544","BK1122","LU0823426308.USD","LU0229945570.USD","LU0210526637.USD","BK1546","EWH","LU0791591158.USD","LU0348735423.USD","LU1282649141.HKD","LU1115378108.SGD","LU0266512473.USD","LU0149721374.USD","HK0001040143.USD","02475","LU0918141887.USD","LU0228367735.SGD","LU1105468828.SGD","LU1688375341.USD","LU0043850808.USD","03328","SG9999002828.SGD","LU0516423174.USD","LU0431992006.USD","LU0106252389.USD","LU0456827905.SGD","BK1161","LU0164880469.USD","02846","LU0463099449.HKD","02359","LU1188198961.HKD","01877","LU1880383440.USD","LU1808992512.USD","IE00B0169L03.USD","LU0543330483.HKD","01812","LU1255011170.USD","LU1251922891.USD","LU0328353924.USD","BK1231","LU0348767384.USD","BK1237","LU1813983027.USD","LU0449509016.USD","06066","LU1720050803.USD","LU0314109678.HKD","LU1244550577.SGD","LU0516423091.SGD","03143","BK1530","LU1366334578.USD","LU0589944569.HKD","BK1523","LU0797268264.HKD","LU1242518931.SGD","LU2125910500.SGD","BK1537","BK1505","LU0106959298.USD","LU0244354667.USD","LU0029875118.USD","LU0417516902.SGD","LU0072913022.USD","IE0031814852.USD","BK1171","LU1328277881.USD","LU0348814723.USD","LU2008162690.USD","LU0164865239.USD","LU0737861699.HKD","LU0181495838.USD","BK1552","03968","LU2476274720.SGD","LU0607220059.USD","03678","HK0000306685.HKD","LU1769817179.HKD","06821","LU0384037296.USD","03986","02865","BK1105","LU0708995583.HKD","LU2097828805.USD","LU2242644610.SGD","02899","LU1655091616.SGD","LU0821914370.USD","LU0516422366.SGD","HK0000352382.USD","LU1719994722.HKD","IE00BZ08YR35.GBP","LU2097828714.EUR","LU3063872942.SGD","LU0320764599.SGD","LU1206782309.USD","LU0326950275.SGD","LU0455707207.USD","LU1988902786.USD","LU2264538146.SGD","LU1008478684.HKD","00042","LU1226287529.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199145560","title":"Tellgen's Subsidiary Device Registration Application Accepted by Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1199145560","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199145560?lang=en_us&edition=fundamental","pubTime":"2026-09-10 11:54","pubTimestamp":1789012483,"startTime":"0","endTime":"0","summary":"Tellgen Corporation (SZSE: 300642) has announced that its controlling subsidiary, Shanghai Maishi Biotechnology Co., Ltd., recently had its medical device registration application accepted for review...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300642","BK0042","HART","09996","BK1574","PTH","GDOC","RSPH","LGHT","MEDX","159883","AGNG","MDEV","BK0046","BK0239","BK1583","LNGR","IEIH","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192676541","title":"Northeast Securities: Innovative Drug BD and Commercialization Deliver Consistent Wins, CXO Exceeds Projections, Traditional Segments Approach Turnaround","url":"https://stock-news.laohu8.com/highlight/detail?id=1192676541","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192676541?lang=en_us&edition=fundamental","pubTime":"2026-09-10 10:08","pubTimestamp":1789006103,"startTime":"0","endTime":"0","summary":"Investment banking firm Northeast Securities Co.,Ltd. has released a research report indicating that the high prosperity of the overseas innovative drug industry is set to continue, allowing domestic...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","IBBQ","WX","000686","BK1161","BK0028","LNGR","BK0188","MEDX","BK0276","BK1574","BK0183","CXO","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175120307","title":"Ascletis Pharma Surges on US Obesity Drug Trial Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=1175120307","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175120307?lang=en_us&edition=fundamental","pubTime":"2026-09-10 09:50","pubTimestamp":1789005025,"startTime":"0","endTime":"0","summary":"Ascletis Pharma-B (01672) shares jumped nearly 5% in early trading, before paring gains to a modest 0.50% increase, reaching HK$10.11 with turnover of HK$1.82 million. The company announced it has...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","01672","BK1574","BK1515","01477","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171834211","title":"Hong Kong Stock Market Highlights: JXR Advances Female Health Translational Medicine Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1171834211","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171834211?lang=en_us&edition=fundamental","pubTime":"2026-09-10 09:04","pubTimestamp":1789002291,"startTime":"0","endTime":"0","summary":"JXR (01951) announced plans to further develop a translational medicine platform primarily focused on female health, marking a strategic move to strengthen its presence in this specialized...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1597","BK1574","02142","BK4585","FHCO","00950","00580","BK1219","BK1191","BK1161","01951","BK1583","KCAI","BK1189","BK4588","VXUS","BK1116","06681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103728541","title":"AI-Driven Drug Candidate From INSILICO Reaches Major Milestone As Phase 3 Trial Enrolls First Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=1103728541","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103728541?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:26","pubTimestamp":1789000007,"startTime":"0","endTime":"0","summary":"INSILICO (03696) has announced that its lead artificial intelligence-powered investigational drug, Rentosertib (also known as ISM001-055/INS018_055), has achieved a significant clinical milestone...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03086","161631","07266","AGIX","PSQ","LCLG","QTOC","TECY","KOMP","WPAI","QSWN","09086","CHAT","MEDX","NEWZ","AIBU","TQQY","NAPR","MVPS","NOCT","QID","03696","159992","03034","IBBQ","AIQU","IBBJ","QQQM","AIFD","BK1161","TQQQ","QDEC","QLD","PBOT","OGIG","09834","BK1141","MDTX","QMAR","02834","06978","CWC","CPNQ","FWD","QQQ","GK","07568","03455","QQQX","GPIQ","DQJN","NJAN","PSYK","TARK","BK1574","07261","07522","ARTY","MFIG","LNGR","VUSE","QQA","NJUL","NBDS","BK4593","SQQQ","BMED","AQGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156894230","title":"LIFETECH SCI's LantvalTM Aortic Valve Replacement System Clears NMPA Fast-Track Review for Innovative Devices","url":"https://stock-news.laohu8.com/highlight/detail?id=1156894230","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156894230?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:08","pubTimestamp":1788998900,"startTime":"0","endTime":"0","summary":"LIFETECH SCI (01302) has announced that it received an official written notice from the National Medical Products Administration (NMPA) on September 9, 2026, confirming that the LantvalTM aortic...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","01302","BK1583","PTH","09996","HART","RSPH","BK1600","AGNG","GDOC","159883","LGHT","BK1100","MDEV","IEIH","LNGR","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":6,"totalSize":224,"code":"91000000","status":"200"}]}}